Question 1

What is UCB Pharma (Belgium) known for?

Accepted Answer

In research, UCB Pharma (Belgium) stands highest in Health Sciences (#4,825 of 9,902 worldwide) and Medicine (#4,325 of 8,541 worldwide), 2022-now.

Question 2

How does UCB Pharma (Belgium) rank in research?

Accepted Answer

UCB Pharma (Belgium) ranks #12,888 of 22,385 institutions worldwide on research quality in 2022-now (#3,440 all time), and #58 of 105 in Belgium.

Question 3

Who are the top researchers at UCB Pharma (Belgium)?

Accepted Answer

Ranked on the quality score, Martin Armstrong, Tanja Tran and Henrik Klitgaard lead among researchers whose main affiliation is UCB Pharma (Belgium).

Question 4

What are the most cited papers from UCB Pharma (Belgium)?

Accepted Answer

The most cited paper from UCB Pharma (Belgium) is "Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016" (Andrew Rhodes et al., 2017), with 3,822 citations. Next come "Romosozumab Treatment in Postmenopausal Women with Osteoporosis" (1,797) and "The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam" (1,624).

Question 5

Which research topics does UCB Pharma (Belgium) publish most on?

Accepted Answer

By volume in 2022-now: Epilepsy research and treatment, Spondyloarthritis Studies and Treatments, Psoriasis: Treatment and Pathogenesis and Health Systems, Economic Evaluations, Quality of Life.

Question 6

Which keywords describe research at UCB Pharma (Belgium)?

Accepted Answer

By fractional works in 2022-now, weighted toward what it does more of than the world: Inflammation, Antiepileptic Drugs, Quality of Life, Autoantibodies, Genetics, Neurological Disorders, Neurobiology and Epilepsy.

Question 7

Which fields of science does UCB Pharma (Belgium) work in?

Accepted Answer

In 2022-now, 51% of research at UCB Pharma (Belgium) is in Health Sciences, 26% in Life Sciences. Its largest fields are Medicine (48%), Biochemistry, Genetics and Molecular Biology (11%), Neuroscience (6%). It does 2.1× the world's share of Health Sciences.

Question 8

Is UCB Pharma (Belgium)'s research output growing?

Accepted Answer

Output in 2022-2025 was 8% lower than in 2018-2021.